Global Biotech Innovators Unite for GenScript’s Annual Forum

GenScript Biotech Corporation, a leader in life sciences research and development, has announced its 5th Annual Biotech Global Forum, set for January 14, 2026, at the San Francisco Marriott Marquis. This event will be held alongside the renowned J.P. Morgan Healthcare Conference, offering both in-person and virtual attendance options. The Forum aims to facilitate discussions around the innovative landscape of biotechnology, particularly focusing on the intersection of scientific discovery and therapeutic advancements.

The theme of this year’s Forum, ‘Scripting Possibilities,’ reflects a commitment to exploring how emerging technologies and computational advancements can reshape the future of cell and gene therapies (CGTs) and next-generation biotherapeutics. Attendees, including scientists, innovators, and investors, will engage in discussions about the latest technologies and collaborations that are vital for accelerating the journey from concept to patient impact.

Sherry Shao, CEO of GenScript Biotech Corp, emphasized the Forum’s importance: “The Global Forum has become a central gathering point for leaders driving progress across the biotech ecosystem. We are proud to bring this community together in San Francisco once again. Our mission is to empower researchers and companies end-to-end—with integrated technologies, platforms and expertise—across the entire lifecycle from discovery to development and manufacturing.”

The event will feature two prominent keynote speakers recognized for their groundbreaking work that merges biology with computational intelligence. Their insights focus on how algorithms can be utilized to design molecules, pushing the limits of what is currently achievable in the field.

Highlighting Transformative Advancements

The Forum is positioned as a pivotal moment in biotechnology, according to Ray Chen, PhD, President of GenScript Life Science Group. He stated, “Biotechnology is at an inflection point—where speed, precision and collaboration are no longer optional. The Global Forum is designed to bring together the leaders scripting what comes next, and to explore ways of pushing the boundaries of what’s seemingly impossible.”

This year’s program showcases a powerful convergence of discovery science, computational intelligence, and therapeutic development. When these elements align, they promise to accelerate scientific discoveries, enhance scalability, and ensure timely access to innovations for patients.

Registration for the GenScript Biotech Global Forum is currently open. Those interested can visit GenScript’s official website for more information and to secure their attendance.

About GenScript Biotech Corporation

Founded in 2002 in New Jersey, GenScript Biotech Corporation has become a critical player in advancing biotechnology and healthcare. The company provides researchers and firms with essential resources to develop innovative treatments and products. Their mission is to “Make People and Nature Healthier Through Biotechnology,” supporting customers throughout the entire innovation process—from early discovery stages to advanced biologics and manufacturing, particularly through their ProBio business.

With a workforce of over 5,700 employees, GenScript has successfully served more than 200,000 customers in over 100 countries. For further information, visit their website at https://www.genscript.com.

Media inquiries can be directed to Stefanie Tuck at CG Life via email at [email protected].